Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Retained-Earnings" stands at 57.92 Billion Japanese Yens as of 06/30/2025, the highest value since 03/31/2024.
As of the end of Sumitomo Dainippon Pharma Co Ltd's first quarter, the item "Retained Earnings" stands at 57.92 Billion JPY. This represents an increase of 23.81 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 22.63 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 22.63 Billion Japanese Yens.
The 3 year change is -481.16 Billion Japanese Yens.
The 5 year change is -412.10 Billion Japanese Yens.
The 10 year change is -268.30 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Retained Earnings | 905,699,262,464.00 |
![]() | Johnson & Johnson - Retained Earnings | 486,508,953,600.00 |
![]() | AbbVie Inc - Retained Earnings | 399,570,305,024.00 |
![]() | Roche Holding AG - Retained Earnings | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Retained Earnings | 280,205,508,085.11 |